ArticleCancer immunology research2025

There and back again: PD-L1 Positivity as a Biomarker for Immune Checkpoint Blockade in Urothelial Carcinoma.

Arivarasan Karunamurthy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.